Research Paper Volume 13, Issue 5 pp 7549—7569

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease

class="figure-viewer-img"

Figure 1. Chemical structure of ginsenoside Rg1.